3,4-dihydroxyphenylacetic acid has been researched along with calpain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amini, M; Anisman, H; Callaghan, S; Kulczycki, J; Mao, Z; Mount, MP; Park, DS; Slack, RS; Zhang, Y | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and calpain
Article | Year |
---|---|
Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Calpain; Cell Death; Cyclin-Dependent Kinase 5; Dopaminergic Neurons; Gene Expression Regulation; Male; MEF2 Transcription Factors; Mice; Mice, Knockout; Myogenic Regulatory Factors; Neurotoxins; Nuclear Receptor Subfamily 4, Group A, Member 1; RNA, Small Interfering; Substantia Nigra | 2013 |